Fragility of cardiovascular outcome trials (CVOTs) examining nutrition interventions among patients with diabetes mellitus: a systematic review of randomized controlled trials
Ημερομηνία
2022Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Purpose: There is controversy regarding the optimal statistical method to interpret how robust is a statistically significant result. The fragility index (FI) and the reverse fragility index (RFI) are quantitative measures that can facilitate the appraisal of a clinical trial’s robustness. This study was performed to evaluate the FI and RFI of randomized controlled trials (RCTs) examining nutritional interventions in patients with diabetes mellitus, focusing on cardiovascular outcomes. Methods: A systematic search was conducted and relevant RCTs were identified in three databases. RCTs examining nutritional interventions (supplements or dietary patterns) in patients with DM with dichotomous primary endpoints involving cardiovascular outcomes were eligible. Data were extracted to compose 2 × 2 event tables and the FI and RFI were calculated for each comparison, using Fisher’s exact test. Risk of bias (RoB) of the included RCTs was assessed with the Cochrane RoB 2.0 tool. Results: A total of 14,315 records were screened and 10 RCTs were included in the analyses. The median FI of the paired comparisons was 3 (IQR: 2–4) and the median RFI was 8 (IQR: 4.5–17). RoB and heterogeneity were low. Conclusions: RCTs examining nutritional interventions and cardiovascular outcomes among patients with diabetes mellitus appear to be statistically fragile. Τhe FI and the RFI can be reported and interpreted as an additional perspective of a trial’s robustness. Highlights: • In the evidence-healthcare era, assessing how robust statistically significant results are remains a matter of controversy. • Recently, the fragility index (FI) and reverse fragility index (RFI) were proposed to assess the robustness of randomized controlled trials (RCTs) with 2 × 2 comparisons. • When applying the FI and RFI, RCTs examining nutritional interventions and cardiovascular outcomes among patients with diabetes mellitus (DM) appear to be statistically fragile. • Τhe FI and the RFI can be reported and interpreted as an additional perspective of a trial’s robustness. • RCTs implementing nutrition interventions among patients with DM can improve their methodology. © 2022, The Author(s).
Collections
Related items
Showing items related by title, author, creator and subject.
-
Two-stage, school and community-based population screening successfully identifies individuals and families at high-risk for type 2 diabetes: The Feel4Diabetes-study
Manios Y., Mavrogianni C., Lambrinou C.-P., Cardon G., Lindström J., Iotova V., Tankova T., Civeira F., Kivelä J., Jancsó Z., Shadid S., Tsochev K., Mateo-Gallego R., Radó S., Dafoulas G., Makrilakis K., Androutsos O. (2020)Background: The implementation of population screening and early prevention strategies targeting individuals at high-risk for type 2 diabetes (T2D) seems to be a public health priority. The current work aimed to describe ... -
Glycaemic control in heart failure: a PARADIGM shift for patients with concomitant diabetes?
Giamouzis G., Butler J. (2017)[No abstract available] -
SGLT-2 inhibitors in diabetic kidney disease: What lies behind their renoprotective properties?
Georgianos P.I., Divani M., Eleftheriadis T., Mertens P.R., Liakopoulos V. (2019)Background: Despite optimal management of diabetic kidney disease (DKD) with intensive glycemic control and administration of agents blocking the renin-angiotensinaldosterone-system, the residual risk for nephropathy ...